Refractory Ovarian Carcinoma Clinical Trials

13 clinical trials for Refractory Ovarian Carcinoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer — RECRUITING · PHASE2
• MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer — RECRUITING · PHASE1
• A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer — RECRUITING · PHASE2
• CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors — RECRUITING · PHASE2
• Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — COMPLETED · PHASE2
• Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors — SUSPENDED · PHASE1
• AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — TERMINATED · PHASE1
• Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients — TERMINATED · PHASE1
• Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — TERMINATED · PHASE1
• A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — COMPLETED · PHASE2

Refine this search